A decade after SARS: strategies for controlling emerging coronaviruses

Nature Reviews. Microbiology
Rachel L GrahamRalph S Baric

Abstract

Two novel coronaviruses have emerged in humans in the twenty-first century: severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), both of which cause acute respiratory distress syndrome (ARDS) and are associated with high mortality rates. There are no clinically approved vaccines or antiviral drugs available for either of these infections; thus, the development of effective therapeutic and preventive strategies that can be readily applied to new emergent strains is a research priority. In this Review, we describe the emergence and identification of novel human coronaviruses over the past 10 years, discuss their key biological features, including tropism and receptor use, and summarize approaches for developing broadly effective vaccines.

References

Jan 1, 1978·Archives of Virology·M B Pensaert, P de Bouck
Jul 12, 1986·The Veterinary Record·D R SnodgrassB A Synge
May 4, 2000·The New England Journal of Medicine·L B Ware, M A Matthay
Apr 12, 2003·The New England Journal of Medicine·Christian DrostenHans Wilhelm Doerr
Apr 12, 2003·The New England Journal of Medicine·Thomas G KsiazekUNKNOWN SARS Working Group
Apr 25, 2003·Lancet·J S M PeirisUNKNOWN SARS study group
Oct 31, 2003·Nature·Byron E E MartinaAlbert D M E Osterhaus
Feb 26, 2004·Nature Medicine·Bart L HaagmansAlbert D M E Osterhaus
Mar 20, 2004·Emerging Infectious Diseases·Bo Jian ZhengShui Shan Lee
Mar 23, 2004·Nature Medicine·Lia van der HoekBen Berkhout
Apr 10, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ron A M FouchierAlbert D M E Osterhaus
Apr 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Himani BishtBernard Moss
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ursula J BuchholzPeter L Collins
Jun 29, 2004·Lancet·Jan ter MeulenAlbert D M E Osterhaus
Aug 13, 2004·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Nanshan Zhong
Aug 18, 2004·International Immunology·Naomi TakasukaYasuko Tsunetsugu-Yokota
Sep 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·William G GlassPhilip M Murphy
Nov 9, 2004·Biochemical and Biophysical Research Communications·Yuxian HeShibo Jiang
Nov 9, 2004·Paediatric Respiratory Reviews·James D Cherry
Dec 4, 2004·Nature Medicine·J S M PeirisK Y Yuen
Dec 15, 2004·Journal of Virology·Anjeanette RobertsKanta Subbarao
Jan 19, 2005·BMC Immunology·Renji ReghunathanAlirio J Melendez
Jan 20, 2005·American Journal of Respiratory and Critical Care Medicine·Yong JiangPeng Deng
Feb 8, 2005·Proceedings of the National Academy of Sciences of the United States of America·Huai-Dong SongGuo-Ping Zhao
May 18, 2005·Proceedings of the National Academy of Sciences of the United States of America·Heike HofmannStefan Pöhlmann

❮ Previous
Next ❯

Citations

Oct 24, 2014·Emerging Infectious Diseases·Samir BenkouitenPhilippe Gautret
Nov 3, 2014·Annual Review of Virology·Everett Clinton SmithMark R Denison
Nov 25, 2014·Emerging Infectious Diseases·Danielle R AdneyVincent J Munster
Aug 12, 2014·Viruses·Ruth McBrideBurtram C Fielding
Apr 14, 2015·Expert Review of Vaccines·Amy B PapaneriJens H Kuhn
Sep 29, 2015·Expert Opinion on Biological Therapy·Lanying Du, Shibo Jiang
Feb 24, 2016·Frontiers in Plant Science·Olivia C DemurtasRosella Franconi
Dec 23, 2015·Virology Journal·Ben HuZhengli Shi
Sep 1, 2015·Preventive Veterinary Medicine·Peter R Davies
Nov 10, 2015·Nature Medicine·Vineet D MenacheryRalph S Baric
May 11, 2015·Archivos de bronconeumología·José María GalvánJavier Aspa
Mar 16, 2016·Proceedings of the National Academy of Sciences of the United States of America·Vineet D MenacheryRalph S Baric
Sep 1, 2015·Experimental & Molecular Medicine·Prasannavenkatesh DuraiSangdun Choi
Oct 4, 2014·Virus Research·Vineet D MenacheryRalph S Baric
Jul 6, 2014·Frontiers in Microbiology·To S Fung, Ding X Liu
Mar 4, 2014·Pathogens and Disease·Shauna Milne-PriceVincent J Munster
Aug 16, 2016·Proceedings of the National Academy of Sciences of the United States of America·Yue Ma-LauerAlbrecht von Brunn
Oct 25, 2016·Trends in Microbiology·Diego ForniManuela Sironi
Feb 24, 2016·Scientific Reports·Vincent J MunsterRichard A Bowen
Jan 26, 2017·Expert Opinion on Therapeutic Patents·Jiwon ChoiYoung Bong Kim
Feb 18, 2017·Pathogens·Alexandra Schäfer, Ralph S Baric
Jun 22, 2017·Hospital Practice·Simone Gattarello, Jordi Rello
Dec 22, 2016·Emerging Microbes & Infections·Jean Kaoru MilletGary R Whittaker
Nov 25, 2017·Nature Communications·Alan H M WongJames M Rini

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
transgenically
PCR

Software Mentioned

PhyML

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Current Opinion in Virology
Lisa M Gretebeck, Kanta Subbarao
Journal of Thoracic Disease
Paul K S Chan, Martin C W Chan
Expert Opinion on Drug Discovery
Allison L Totura, Sina Bavari
Journal of Thoracic Disease
Kelvin K W ToKwok-Yung Yuen
© 2021 Meta ULC. All rights reserved